Spin-off Reveal Genomics born to develop innovative diagnostic tests in oncology
Reveal Genomics’ first goal will be to develop diagnostic tools based on complex genomic data for patients with advanced breast cancer.
Reveal Genomics’ first goal will be to develop diagnostic tools based on complex genomic data for patients with advanced breast cancer.
MethinksLVO software is able to detect vaso-occlusion in less than two minutes using non-contrast CT images. The algorithm’s interpretation of the1
Congenital metabolic disorders are rare diseases caused by alterations when ingested nutrients are processed. They can cause the accumulation or defi1
An AI model based on information from more than three thousand clinical reports generated by the Hospital Clínic during the acute phase of the pandem1
The low blood sugar (glucose) levels experienced by people with diabetes can affect the brain. A sudden drop in glucose causes neuronal death and, as1
Active smokers who have chronic obstructive pulmonary disease (COPD) are more likely to present serious forms of COVID-19. There are yet no studies c1
Approximately 800,000 children and 1 million elderly people died of pneumonia around the world in 2017. Nevertheless, the severity of pneumonia is of1
COVID-19 affects people with Parkinson’s disease in a similar way to the general population, but it may be more serious in cases of advanced disease.1
In a retrospective study with 80 kidney transplant patients with COVID-19, treatment with tocilizumab demonstrates a decrease in one of the inflammat1
The pandemic and lockdown caused by COVID-19 have increased symptoms of anxiety and depression in the population. However, according to a major surve1